Consensus statement on hemostatic management, anticoagulation, and antiplatelet therapy in liver transplantation
E Montalvá, M Rodríguez-Perálvarez, A Blasi… - …, 2022 - journals.lww.com
Anticoagulation and antiplatelet therapies are increasingly used in liver transplant (LT)
candidates and recipients due to cardiovascular comorbidities, portal vein thrombosis, or to …
candidates and recipients due to cardiovascular comorbidities, portal vein thrombosis, or to …
Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients
Q Li, X Ma, Q Shao, Z Yang, Y Wang, F Gao… - Frontiers in …, 2022 - frontiersin.org
Background The aim of this study was to evaluate the prognostic values of five lymphocyte-
based inflammatory indices (platelet-lymphocyte ratio [PLR], neutrophil-lymphocyte ratio …
based inflammatory indices (platelet-lymphocyte ratio [PLR], neutrophil-lymphocyte ratio …
Meta-analysis on the efficacy of high-dose statin loading before percutaneous coronary intervention in reducing no-reflow phenomenon in acute coronary syndrome
S Anayat, K Majid, HS Nazir, AA Nizami… - The American journal of …, 2023 - Elsevier
Currently, guidelines recommend the uptake of high-dose statins before and after
percutaneous coronary intervention (PCI) in patients with acute coronary syndrome …
percutaneous coronary intervention (PCI) in patients with acute coronary syndrome …
The prognostic value of hematologic inflammatory markers in patients with acute coronary syndrome undergoing percutaneous coronary intervention
W Fan, C Wei, Y Liu, Q Sun, Y Tian… - Clinical and Applied …, 2022 - journals.sagepub.com
The aggregate index of systemic inflammation (AISI), systemic inflammation response index
(SIRI), and neutrophil-to-lymphocyte* platelet ratio (NLRP) are novel indices that …
(SIRI), and neutrophil-to-lymphocyte* platelet ratio (NLRP) are novel indices that …
Anti-angiogenic effect of exo-LncRNA TUG1 in myocardial infarction and modulation by remote ischemic conditioning
Y Dang, W Hua, X Zhang, H Sun, Y Zhang, B Yu… - Basic Research in …, 2023 - Springer
The successful use of exosomes in therapy after myocardial infarction depends on an
improved understanding of their role in cardiac signaling and regulation. Here, we report …
improved understanding of their role in cardiac signaling and regulation. Here, we report …
The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do
P Wang, H Qiao, RJ Wang, R Hou, J Guo - BMC Cardiovascular Disorders, 2020 - Springer
Background Percutaneous coronary intervention (PCI) is a common treatment for patients
with coronary heart disease, and intra-stent restenosis (ISR) is a serious complication after …
with coronary heart disease, and intra-stent restenosis (ISR) is a serious complication after …
[PDF][PDF] 冠状动脉功能学和腔内影像学评价进展
曾秋棠， 程翔， 彭昱东 - 临床心血管病杂志, 2021 - lcxxgen.whuhzzs.com
冠状动脉功能学和腔内影像学评价进展 Page 1 临床心血管病杂志 2021,37
JournalofClinicalCardiology(China) (5):398-401 ·专家论坛· 冠状动脉功能学和腔内影像学评价 …
JournalofClinicalCardiology(China) (5):398-401 ·专家论坛· 冠状动脉功能学和腔内影像学评价 …
The systemic inflammation index predicts poor clinical prognosis in patients with initially diagnosed acute coronary syndrome undergoing primary coronary …
Y Gao, Y Li, X Chen, C Wu, Z Guo, G Bai… - Journal of …, 2023 - Taylor & Francis
Background Systemic inflammation index (SII: neutrophil count* platelet count/lymphocyte
count) is a new inflammatory marker that can reflect the degree of systemic inflammatory …
count) is a new inflammatory marker that can reflect the degree of systemic inflammatory …
Efficacy and safety of drug-coated balloon for de novo lesions of large coronary arteries: Systematic review and meta-analysis of randomized controlled trials
JL Jiang, QJ Huang, MH Chen - Heliyon, 2024 - cell.com
Background Drug-coated balloon (DCB) is a novel approach to avoiding stent-related
complications and has proven effective for the treatment of in-stent restenosis (ISR) and …
complications and has proven effective for the treatment of in-stent restenosis (ISR) and …
Eptifibatide, an older therapeutic peptide with new indications: from clinical pharmacology to everyday clinical practice
G Tonin, J Klen - International Journal of Molecular Sciences, 2023 - mdpi.com
Therapeutic peptides are oligomers or short polymers of amino acids used for various
medical purposes. Peptide-based treatments have evolved considerably due to new …
medical purposes. Peptide-based treatments have evolved considerably due to new …